Literature DB >> 24929509

[The molecular mechanism of necroptosis].

Ba Wei1, Pang Yue1, Li Qingwei1.   

Abstract

Programmed necrosis called necroptosis, is different from traditional necrosis and apoptosis, it has attracted considerable attention over the last few years. Necroptosis can be initiated through many factors such as tumor necrosis factor receptor (TNFR) or pattern recognition receptor (PRR), and receptor-interacting protein (RIP) 1 and 3 are two key proteins during the process. A lot of molecules have been characterized as modulators and effectors of necroptosis, including poly(ADP-ribose) polymerase (PARP-1), reactive oxygen species (ROS), Ca(2+), which can destruct mitochondria or other organelles and induce cell dead through caspase-independent pathway. Then, damage-associated molecular pattern (DAMP) molecules were released from necroptosis cells, recognized and internalized by phagocytes. Here, we briefly discuss the initiation and execution of necroptosis and the clearance of death cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24929509     DOI: 10.3724/SP.J.1005.2014.0519

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  3 in total

1.  Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygen‑glucose deprivation‑induced necroptosis.

Authors:  Liming Yuan; Zhen Wang; Lihua Liu; Xiaohong Jian
Journal:  Mol Med Rep       Date:  2015-05-13       Impact factor: 2.952

2.  TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells.

Authors:  Xiao Wu; Meng-Yao Wu; Min Jiang; Qiaoming Zhi; Xiaojie Bian; Meng-Dan Xu; Fei-Ran Gong; Juan Hou; Min Tao; Liu-Mei Shou; Weiming Duan; Kai Chen; Meng Shen; Wei Li
Journal:  Cancer Cell Int       Date:  2017-01-23       Impact factor: 5.722

3.  Innate Immune Cell Recovery Is Positively Regulated by NLRP12 during Emergency Hematopoiesis.

Authors:  Brandon M L Linz; Crystal J Neely; Laurel B Kartchner; April E Mendoza; Amal L Khoury; Agnieszka Truax; Gregory Sempowski; Timothy Eitas; June Brickey; Jenny P Y Ting; Bruce A Cairns; Robert Maile
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.